Toggle light / dark theme

All three of these surprising achievements are highlighted in the Goalkeepers 2018 Data Report, written by Bill and Melinda Gates and released on Sept. 18. But the dispatch—an assessment of the progress made so far on the United Nations’ 17 Sustainable Development Goals and done with the help of the University of Washington’s Institute for Health Metrics and Evaluation—is anything but rah-rah. For every encouraging data point, indeed, there is one that alarms. For every promising advance in the global war on poverty and disease is a perilous outcome if we lose focus or steam.


A report from the Bill & Melinda Gates Foundation focuses on four key areas: Health, education, sanitation, and family planning.

Read more

Here’s a slider photo of Planet satellite images showing Barangay Ucab, Itogon, Benguet before and after the Typhoon #OmpongPH-induced landslide event.


Create stories with Planet.

Read more

On Jan. 1, NASA’s New Horizons will perform a high-risk, high-reward flyby of an ancient world on the outskirts of the solar system.


NASA’s New Horizons spacecraft is just over 100 days away from a high-risk, high-reward flyby of an ancient world on the outskirts of the solar system.

On New Year’s Day 2019, the spacecraft will come within 3,500 kilometers of 2014 MU69, an estimated 37-kilometer-wide object the mission team has nicknamed Ultima Thule. The encounter will take place 6.6 billion kilometers from Earth, where it takes more than 6 hours for radio signals traveling at the speed of light to reach NASA’s Deep Space Network.

There will only be one chance for New Horizons to perfectly aim its cameras and science instruments at Ultima Thule as it zips past at 14 kilometers per second, and there may be unforeseen hazards in the spacecraft’s path. Nevertheless, Jim Green, the director of NASA’s planetary science division, is looking forward to the drama.

Giving millions of patients already taking statins a new type of drug could slash their heart disease risk even further, research suggests.

Scientists claim pills that are currently under development, called lipoprotein lipase (LPL) enhancers, could prevent thousands of heart attacks.

And their study also showed the drugs — which work by lowering levels of fats in the blood — could also slash the risk of type 2 diabetes.

Read more